TR201104108A2 - Uzatılmış salımlı memantin tablet. - Google Patents

Uzatılmış salımlı memantin tablet.

Info

Publication number
TR201104108A2
TR201104108A2 TR2011/04108A TR201104108A TR201104108A2 TR 201104108 A2 TR201104108 A2 TR 201104108A2 TR 2011/04108 A TR2011/04108 A TR 2011/04108A TR 201104108 A TR201104108 A TR 201104108A TR 201104108 A2 TR201104108 A2 TR 201104108A2
Authority
TR
Turkey
Prior art keywords
prolonged release
release memantine
memantine tablets
tablets
composition
Prior art date
Application number
TR2011/04108A
Other languages
English (en)
Inventor
Bulgur Abdullah
Original Assignee
Ali̇ Rai̇f İlaç Sanayi̇ A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. filed Critical Ali̇ Rai̇f İlaç Sanayi̇ A.Ş.
Priority to TR2011/04108A priority Critical patent/TR201104108A2/tr
Publication of TR201104108A2 publication Critical patent/TR201104108A2/tr
Priority to EP12003038A priority patent/EP2517696A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş memantin hidroklorür içeren uzatılmış salımlı farmasötik kompozisyonla ilgilidir. Kompozisyon matris tipi olup, salımı kontrol eden polimer olarak polietilenoksit içerir Hemen salım sağlayan ve uzatılmış salım sağlayan iki tabakalı tablet veya uzatılmış salım sağlayan tablet çekirdeği ve hemen salım sağlayan kaplama şeklinde yapılabilir.
TR2011/04108A 2011-04-27 2011-04-27 Uzatılmış salımlı memantin tablet. TR201104108A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/04108A TR201104108A2 (tr) 2011-04-27 2011-04-27 Uzatılmış salımlı memantin tablet.
EP12003038A EP2517696A1 (en) 2011-04-27 2012-04-27 Extended release memantine tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/04108A TR201104108A2 (tr) 2011-04-27 2011-04-27 Uzatılmış salımlı memantin tablet.

Publications (1)

Publication Number Publication Date
TR201104108A2 true TR201104108A2 (tr) 2011-08-22

Family

ID=44950498

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/04108A TR201104108A2 (tr) 2011-04-27 2011-04-27 Uzatılmış salımlı memantin tablet.

Country Status (2)

Country Link
EP (1) EP2517696A1 (tr)
TR (1) TR201104108A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2623176T3 (es) * 2012-08-16 2017-07-10 Teva Pharmaceutical Industries Ltd. Composición farmacéutica de memantina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4225730C2 (de) 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
US8039009B2 (en) 2004-06-17 2011-10-18 Forest Laboratories Holdings Limited Modified release formulations of memantine oral dosage forms
RU2445092C2 (ru) * 2005-04-28 2012-03-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Композиция, содержащая средство против деменции
WO2006138227A1 (en) 2005-06-16 2006-12-28 Forest Laboratories, Inc. Modified and immediate release memantine bead formulation
US20130323309A1 (en) * 2011-02-17 2013-12-05 Lupin Limited Sustained Release Composition of Memantine

Also Published As

Publication number Publication date
EP2517696A1 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
AR114143A2 (es) Formulaciones de comprimidos revestidos
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
CR20150326A (es) Inhibidores de autotaxina
EA201400986A1 (ru) Фармацевтические композиции, содержащие метформин и ингибитор dpp-4 или ингибитор sglt-2
GT201300166A (es) Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas
BR112013022789A2 (pt) composições farmacêuticas que compreendem metformina e um inibidor dpp-4 ou um inibidor sglt-2
PE20131125A1 (es) Forma de dosificacion resistente a alteracion que comprende un polimero anionico
MA34091B1 (fr) Anticorps anti-cd40
EA201170616A1 (ru) Лекарственная форма ацетаминофен/трамадол с замедленным действием для перорального приема
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
EA201591830A1 (ru) Фармацевтические композиции, включающие эверолимус
CL2013000488A1 (es) Co-cristales de compuestos derivados de (2r)-5-oxo-1-(bencilpiperidin-4-il)-n-(piridin-2-il)pirrolidin-2-carboxamida y un agente de formacion de co-cristales; sales de los compuestos; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias e infecciosas.
BR112014025041B8 (pt) Composição farmacêutica
BR112014002025A2 (pt) partículas que compreendem compostos ativos com base em poliacrilato
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
ES2415029R1 (es) Composición farmacéutica y método para inhibir la producción o amplificar la eliminación de la proteína P24.
UA113977C2 (xx) Фармацевтична композиція з покращеною стабільністю
BR112018068370A2 (pt) composição farmacêutica em dose fixa contendo amlodipina, candesartan cilexetil e hidroclorotiazida para o tratamento de hipertensão
AR118842A2 (es) Composición farmacéutica que contiene tamoxifen y endoxifen y procedimiento para prepararla
EA201300079A3 (ru) Фармацевтическая композиция для пролонгированного высвобождения триметазидина
TR201104108A2 (tr) Uzatılmış salımlı memantin tablet.